At a time when India’s healthcare ecosystem faces mounting challenges from chronic wounds—driven by aging, diabetes, obesity, and trauma—alongside an increasing preference for aesthetic treatments, MedVital, a next-generation healthcare startup focused on wound care and minimally invasive aesthetics, has announced a successful pre-seed funding round of ₹8.4 crore.
The investment was spearheaded by Nihar Parikh’s 4point0 Health Ventures and included backing from a distinguished group of operator-investors, including founders from Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk. MedVital aims to close critical access gaps with advanced, outcome-driven technologies.
With its mission rooted in making skin repair, restoration, and regeneration more efficient and accessible, MedVital is introducing India’s first integrated platform focused on complex wound care and minimally invasive aesthetic solutions—areas that remain largely underserved.
At the forefront of this innovation is NoWound™, a next-gen Negative Pressure Wound Therapy (NPWT) device. Built to serve hospitals, clinics, and even home-care settings, NoWound™ distinguishes itself from legacy NPWT systems with its compact form factor, digital integration, and local manufacturing, enabling deployment even in low-resource environments.
“MedVital was founded on the belief that skin repair and restoration deserve the same level of innovation and investment as any other critical area of medicine. We are building a full-stack platform that integrates clinically proven devices, intelligent monitoring, and next-generation biomaterials to transform how complex wounds are treated and how patients recover. Our goal is to become a trusted partner for specialists restoring a patient’s skin, preventing diabetic amputations, or helping individuals regain confidence through aesthetic enhancements. Our mission is simple: to make advanced solutions accessible and fairly priced for everyone,” said Dr. Varun Gupta, Co-Founder and CEO, MedVital.
The funding will scale operations, diversify the product portfolio, and extend the company’s distribution network to include tertiary hospitals, rural clinics, and home-care centres, strengthening infrastructure to meet the growing demand.
Also Read :- Hyderabad Strengthens Global Position as Life Sciences Manufacturing Powerhouse: CBRE Reports
Tarun Bansal, Co-Founder and COO of MedVital, stated, “Our vision is to make India a global hub for cutting-edge wound care and skin restoration solutions. This funding gives us the fuel to scale responsibly, building a system that works not just in ICUs, but in homes and clinics across the country.”
Investors are optimistic about the company’s direction and market relevance.
“We invest in teams that understand and address India’s healthcare challenges on a large scale. MedVital’s strategic approach to hard-to-heal wound management and minimally invasive treatments positions them uniquely in the healthcare landscape. Their focus on improving accessibility of high-quality science backed with measurable clinical outcomes addresses exactly what the market demands,” said Nihar Parikh, Founder of 4point0 Health Ventures.
Looking ahead, MedVital is set to expand into liquid chitosan-based dressings for chronic wound management and explore new frontiers in dermal and hair regeneration, bridging the gap between therapeutic and aesthetic medicine.
With a strong innovation pipeline and a vision aligned with India’s healthcare priorities, MedVital is positioning itself as a future-defining leader in regenerative medicine, backed by science, built in India, and designed for global impact.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
